Vaccine News: Clinical development [November 4-November 11]

Clinical development Mayo Clinic is working on breast cancer vaccines 10 Nov, 2024 Cleveland Clinic presents new findings on triple-negative breast cancer vaccine 09 Nov, 2024 Anixa Biosciences Reports Promising Phase 1 Vaccine Results 08 Nov, 2024 Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu Shots 08 Nov, 2024 Dynavax drops Read more…

Vaccine News: Research [November 4-November 11]

Research WHO Identifies 17 Top Priority Pathogens for New Vaccine Development 11 Nov, 2024 Irradiated whole cell Chlamydia vaccine confers significant protection in a murine genital tract challenge model 11 Nov, 2024 Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection 09 Nov, 2024 Bacteriophage RNA polymerases: Read more…

Vaccine News: Research [October 28-November 4]

Research Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination 02 Nov, 2024 Mucosal Vaccination with Outer Membrane Vesicles Derived from Bordetella pertussis reduces Nasal Bacterial Colonization after experimental infection 01 Nov, 2024 Tonix Pharmaceuticals presents data on TNX-801 at World Vaccine Congress 01 Nov, 2024 When Read more…

Polygon Health Analytics Launches First Cohort of Launchpad Program

Polygon Health Analytics is excited to announce the successful graduation of the first cohort of its Launchpad Program, a 3-to-6-month train-to-hire initiative designed to prepare emerging talents for roles in real-world data (RWD), real-world evidence (RWE), and health economics and outcomes research (HEOR). This milestone reflects Polygon’s commitment to cultivating a Read more…